Clinical utility of CA-125 in the management of uterine carcinosarcoma

Koji Matsuo, Malcolm S Ross, Mayu Yunokawa, Marian S Johnson, Hiroko Machida, Kohei Omatsu, Merieme M Klobocista, Dwight D Im, Shinya Satoh, Tsukasa Baba, Yuji Ikeda, Stephen H Bush, Kosei Hasegawa, Erin A Blake, Munetaka Takekuma, Masako Shida, Masato Nishimura, Sosuke Adachi, Tanja Pejovic, Satoshi TakeuchiTakuhei Yokoyama, Yutaka Ueda, Keita Iwasaki, Takahito M Miyake, Shiori Yanai, Tadayoshi Nagano, Tadao Takano, Mian Mk Shahzad, Frederick R Ueland, Joseph L Kelley, Lynda D Roman

Research output: Contribution to journalArticle

2 Citations (Scopus)
Original languageEnglish
Pages (from-to)e88
JournalJournal of gynecologic oncology
Volume29
Issue number6
DOIs
Publication statusPublished - Nov 2018
Externally publishedYes

Keywords

  • CA-125 Antigen
  • Carcinosarcoma
  • Female
  • Humans
  • United States
  • Uterine Neoplasms

Cite this

Matsuo, K., Ross, M. S., Yunokawa, M., Johnson, M. S., Machida, H., Omatsu, K., Klobocista, M. M., Im, D. D., Satoh, S., Baba, T., Ikeda, Y., Bush, S. H., Hasegawa, K., Blake, E. A., Takekuma, M., Shida, M., Nishimura, M., Adachi, S., Pejovic, T., ... Roman, L. D. (2018). Clinical utility of CA-125 in the management of uterine carcinosarcoma. Journal of gynecologic oncology, 29(6), e88. https://doi.org/10.3802/jgo.2018.29.e88